levetiracetam 500 mg

1 INDICATIONS & USAGE Levetiracetam Extended-Release Tablets are indicated for the treatment of partial-onset seizures in patients 12 years of age and older. Levetiracetam Extended-Release Tablets are indicated for the treatment of partial-onset seizures in patients 12 years of age and older ( 1 )

nivagen pharmaceuticals, inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] seizure` `[4] adverse drug reaction` `[5] fatigue` `[6] headache` `[7] alopecia` `[8] nausea` `[9] pain` `[10] dizziness`

8 months ago

OVAL WHITE I

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

LEVETIRACETAM Extended-Release Tablets 500 mg are white to off-white film coated oval tablets with "I" imprinted in black on one side. They are supplied in white HDPE bottles containing 500 tablets (NDC 75834-245-05), and in bottles with child-resistant closure containing 60 tablets (NDC 75834-245-60).

LEVETIRACETAM Extended-Release Tablets 750 mg are white to off-white film coated oval tablets with "II" imprinted in black on one side. They are supplied in white HDPE bottles containing 500 tablets (NDC 75834-246-05), and in bottles with child-resistant closure containing 60 tablets (NDC 75834-246-60). 16.2 Storage Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].

More pills like OVAL I

Related Pills

gemfibrozil 600 mg

bryant ranch prepack

esomeprazole 20 mg

dr. reddys laboratories inc

day time with pe dayquil liquid

aaron industries

nizoral ketoconazole 200 mg tablet

janssen pharmaceutical products

Trazodone Hydrochloride 100 MG Oral Tablet

Pliva Inc.

naproxen sodium 220 MG naproxen 200 MG Oral Tablet

Amneal Pharmaceuticals

Singulair 10 MG Oral Tablet

Merck Sharp & Dohme Corp.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site